Hira Shaikh

15PUBLICATIONS
54CO-AUTHORS
Gene and molecular therapyMedical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 25, 2026
Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC.

|Mar 14, 2026
A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC Group.

Maha Hameed, Alma Habib, Abdullah Mohammad Khan

|Feb 26, 2026
BCMA-Directed CAR T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma and Renal Impairment.

Alma Habib, Nausheen Ahmed, Abdullah Mohammad Khan

|Jan 27, 2026
American Society of Hematology 2026 guidelines on diagnosis of light chain amyloidosis.

Vishal Kukreti, Matthew D Seftel, Maria Adela Aguirre

|Jan 16, 2026
Molecular Profiling and Real-world Outcomes of BRAF V600E-Mutated Papillary Thyroid Cancer.

Martina Chirra, Andrew Elliott, Hira Shaikh

|Dec 24, 2021
Genomic and Molecular Profiling of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Blockade Compared to Survival Outcomes.

Hira Shaikh, Julie E McGrath, Brittany Hughes

Pageof 3

Frequent Collaborators

3 joint publications

Al-Ola Abdallah

3 joint publications

Shebli Atrash

3 joint publications

Zahra Mahmoudjafari

3 joint publications

Abdullah Mohammad Khan